These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 19889788)

  • 1. Genetic changes associated with glycopeptide resistance in Staphylococcus aureus: predominance of amino acid substitutions in YvqF/VraSR.
    Kato Y; Suzuki T; Ida T; Maebashi K
    J Antimicrob Chemother; 2010 Jan; 65(1):37-45. PubMed ID: 19889788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of amino acid changes in the yvqF, vraSR, graSR, and tcaRAB genes from vancomycin intermediate resistant Staphylococcus aureus.
    Yoo JI; Kim JW; Kang GS; Kim HS; Yoo JS; Lee YS
    J Microbiol; 2013 Apr; 51(2):160-5. PubMed ID: 23625215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiological and clinical study of methicillin-resistant Staphylococcus aureus (MRSA) carrying VraS mutation: changes in susceptibility to glycopeptides and clinical significance.
    Kato Y; Suzuki T; Ida T; Maebashi K; Sakurai M; Shiotani J; Hayashi I
    Int J Antimicrob Agents; 2008 Jan; 31(1):64-70. PubMed ID: 18029148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of a vancomycin-intermediate Staphylococcus aureus (VISA) strain by two amino acid exchanges in VraS.
    Berscheid A; François P; Strittmatter A; Gottschalk G; Schrenzel J; Sass P; Bierbaum G
    J Antimicrob Chemother; 2014 Dec; 69(12):3190-8. PubMed ID: 25103491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenem.
    Katayama Y; Murakami-Kuroda H; Cui L; Hiramatsu K
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3190-6. PubMed ID: 19451283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic pathway in acquisition and loss of vancomycin resistance in a methicillin resistant Staphylococcus aureus (MRSA) strain of clonal type USA300.
    Gardete S; Kim C; Hartmann BM; Mwangi M; Roux CM; Dunman PM; Chambers HF; Tomasz A
    PLoS Pathog; 2012 Feb; 8(2):e1002505. PubMed ID: 22319446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-specific mutation of Staphylococcus aureus VraS reveals a crucial role for the VraR-VraS sensor in the emergence of glycopeptide resistance.
    Galbusera E; Renzoni A; Andrey DO; Monod A; Barras C; Tortora P; Polissi A; Kelley WL
    Antimicrob Agents Chemother; 2011 Mar; 55(3):1008-20. PubMed ID: 21173175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of β-Glycosylated Wall Teichoic Acids in the Reduction of Vancomycin Susceptibility in Vancomycin-Intermediate Staphylococcus aureus.
    Hort M; Bertsche U; Nozinovic S; Dietrich A; Schrötter AS; Mildenberger L; Axtmann K; Berscheid A; Bierbaum G
    Microbiol Spectr; 2021 Oct; 9(2):e0052821. PubMed ID: 34668723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of selected gene mutations to resistance in clinical isolates of vancomycin-intermediate Staphylococcus aureus.
    Hafer C; Lin Y; Kornblum J; Lowy FD; Uhlemann AC
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5845-51. PubMed ID: 22948864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational analyses of open reading frames within the vraSR operon and their roles in the cell wall stress response of Staphylococcus aureus.
    McCallum N; Meier PS; Heusser R; Berger-Bächi B
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1391-402. PubMed ID: 21220524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of stop codons in development and loss of vancomycin non-susceptibility in methicillin-resistant Staphylococcus aureus.
    Doddangoudar VC; O'Donoghue MM; Chong EY; Tsang DN; Boost MV
    J Antimicrob Chemother; 2012 Sep; 67(9):2101-6. PubMed ID: 22643192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional profiling of the two-component regulatory system VraSR in Staphylococcus aureus with low-level vancomycin resistance.
    Chen H; Xiong Z; Liu K; Li S; Wang R; Wang X; Zhang Y; Wang H
    Int J Antimicrob Agents; 2016 May; 47(5):362-7. PubMed ID: 27084050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure of Staphylococcus aureus to subinhibitory concentrations of β-lactam antibiotics induces heterogeneous vancomycin-intermediate Staphylococcus aureus.
    Roch M; Clair P; Renzoni A; Reverdy ME; Dauwalder O; Bes M; Martra A; Freydière AM; Laurent F; Reix P; Dumitrescu O; Vandenesch F
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5306-14. PubMed ID: 24957836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete Reconstitution of the Vancomycin-Intermediate Staphylococcus aureus Phenotype of Strain Mu50 in Vancomycin-Susceptible S. aureus.
    Katayama Y; Sekine M; Hishinuma T; Aiba Y; Hiramatsu K
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3730-42. PubMed ID: 27067329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of vancomycin nonsusceptible strains in clinical isolates of Staphylococcus aureus in northern Iran.
    Asadpour L; Ghazanfari N
    Int Microbiol; 2019 Dec; 22(4):411-417. PubMed ID: 30811005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VraT/YvqF is required for methicillin resistance and activation of the VraSR regulon in Staphylococcus aureus.
    Boyle-Vavra S; Yin S; Jo DS; Montgomery CP; Daum RS
    Antimicrob Agents Chemother; 2013 Jan; 57(1):83-95. PubMed ID: 23070169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
    Cui L; Neoh HM; Shoji M; Hiramatsu K
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1231-4. PubMed ID: 19124662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Underestimation of vancomycin and teicoplanin MICs by broth microdilution leads to underdetection of glycopeptide-intermediate isolates of Staphylococcus aureus.
    Vaudaux P; Huggler E; Bernard L; Ferry T; Renzoni A; Lew DP
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3861-70. PubMed ID: 20547791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus.
    Kuroda M; Kuroda H; Oshima T; Takeuchi F; Mori H; Hiramatsu K
    Mol Microbiol; 2003 Aug; 49(3):807-21. PubMed ID: 12864861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic analysis reveals a point mutation in the two-component sensor gene graS that leads to intermediate vancomycin resistance in clinical Staphylococcus aureus.
    Howden BP; Stinear TP; Allen DL; Johnson PD; Ward PB; Davies JK
    Antimicrob Agents Chemother; 2008 Oct; 52(10):3755-62. PubMed ID: 18644967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.